Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Do You Have A Prior Kidney Condition?

If Yes, Please Describe Your Kidney Condition

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Digitek Side Effects May Be Linked To Bradycardia Lawsuits

Digitek | Lawsuit, Lawyers | Side Effects: Bradycardia, Irregular Heart Rhythms

The Digitek lawyers and attorneys at our firm are currently offering free case evaluations to anyone who suffered an adverse reaction from Digitek tablets. In April 2008, Actavis Towtowa recalled all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP, all strengths) for oral use due to a manufacturing defect.

The Food and Drug Administration (FDA) said the Digitek defect could expose users to twice the amount of active ingredient, which could cause serious and even fatal reactions.

The FDA received several reports of illnesses and injuries in patient taking Digitek. Actavis said it had 11 such reports. But because not all adverse reactions are reported to the FDA or manufacturers, the Digitek injury lawyers at our firm believe that there are far more victims of this defective drug.

Digitek, manufactured by Actavis Towtowa, is sold by Mylan Pharmaceuticals Inc., under a Bertek label and by UDL Laboratories, Inc. under a label. Digitek is a form of digitalis, a chemical derived from the foxglove plant that has been used as a heart medicine since the 18th century. The medication is sold generically as digoxin by several companies.

Digitalis medicines strengthen the force of the heartbeat by increasing the amount of calcium in the heart's cells. When the medicine reaches the heart muscle, it binds to sodium and potassium receptors. These receptors control the amount of calcium in the heart muscle by stopping the calcium from leaving the cells. As calcium builds up in the cells, it causes a stronger heartbeat.

Digitalis medicines also control irregular heart rhythms (called arrhythmias) by slowing the signals that start in the sinoatrial (SA) node. This, in turn, reduces the number of signals that travel through the atrioventricular (AV node). Fewer signals mean fewer arrhythmias.

Digitalis toxicity is a complication of digitalis therapy and may be caused by an acute ingestion of digitalis. Digitalis toxicity can occur from a single exposure or chronic over-medication.

People with heart failure are commonly given diuretics (medications used to pull excess fluid from the body) along with digoxin. Many diuretics can cause potassium loss. Low levels of potassium in the body increase the risk of digitalis toxicity. Digitalis toxicity may also result from low levels of magnesium in the body.

Reduced kidney function will cause digitalis to accumulate in the body rather than being excreted normally through urine. Therefore, any disorders that disrupt kidney functioning (including dehydration) make digitalis toxicity more likely.

Digitek Recall

On April 25, 2008, Actavis Towtowa recalled its Digitek tablets because there existed a possibility that tablets with double the appropriate thickness may have been commercially released. The FDA deemed the Digitek recall a Class I recall, meaning that the defective Digitek tables could cause serious health problems or death.

Our Digitek injury lawyers have determined that Actavis' failure to keep these Digitek tablets away from consumers constitutes an act of negligence, and we are determined to hold this manufacturer accountable.

A double-strength Digitek tablet poses a serious risk of digitalis toxicity in those patients suffering from renal failure. Digitalis toxicity can cause nausea, vomiting, diarrhea, dizziness, confusion, loss of appetite, low blood pressure, cardiac instability and irregular pulse, heart palpitations, and bradycardia. Bradycardia is a slower than normal heartbeat rate, Vision changes such as halos or light rings around objects, seeing lights and bright colors, experiencing changes in color perception, blind spots in vision, and blurred vision can also occur. Patients suffering digitalis toxicity can also experience decreased urine output and excessive nighttime urination, overall swelling, decreased consciousness, and difficulty breathing when lying down. At its most severe, death can result from excessive Digitalis intake.

Both Actavis and the FDA said retailers who have Digitek tablets in stock should return the product.Consumers with medical questions should contact their health care providers. Consumers were also told they could obtain more information on the Digitek recall by calling the Stericycle customer service line at 1-888-276-6166.  Additional information about the Digitek recall can also be found at the Actavis Website at:

The FDA has urged anyone suffering from digitalis toxicity after taking Digitek to make a report to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville or on the MedWatch website at

Legal Help for Victims of Digitek

If you or a loved one suffered from digitalis toxicity as a result of defective Digitek, you have valuable legal rights. Please fill out our online form or call us at 1-800-YOURLAWYER (1-800-968-7529) to speak to an experienced Digitek injury lawyer.


DigitekRSS Feed

Actavis Reopens Plant Closed After Digitek, Other Drug Recalls

Apr 20, 2009 | Parker Waichman LLP
Actavis Totowa has received approval from the Food & Drug Administration (FDA) to reintroduce Oxycodone tablets made at its Little Falls, NJ facility.  The Little Falls plant was one of three closed last year following recalls of oversized Digitek (Digoxin) tablets and other defective generic drugs.Actavis agreed to temporarily close its Little Falls manufacturing facility, as well as another in Riverview and a packaging plant in Taft as part of a Consent Decree it reached with federal...

Generic Digoxin Tablets Recalled

Mar 31, 2009 | Parker Waichman LLP
Potentially defective digoxin tablets have been recalled by generic drug maker Caraco Pharmaceutical Laboratories, Ltd.  According to the recall notice, the tablets may differ in size and therefore could contain too much or too little of the drug's active ingredient.  The recall applies to all tablets of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September,...

Actavis Agrees to Close Digitek Plant

Dec 30, 2008 | Parker Waichman LLP
Actavis Totowa announced today that it has agreed to temporarily close its Little Falls, New Jersey manufacturing facility, as well as another in Riverview and a packaging plant in Taft as part of a Consent Decree it has reached with federal regulators.  The Little Falls Actavis plant made several generic drugs, including Digitek, that were subject to recalls this year.Actavis said in a press release that the Consent Decree reached with the Food & Drug Administration settles the issues...

Digitek Deaths May Have Topped 600

Dec 24, 2008 | Parker Waichman LLP
A new report says that Digitek tablets have been named a suspect in more than 600 deaths. Digitek tablets were recalled in April by Actavis Totowa because of a manufacturing defect.  Actavis said at the time that some Digitek tablets might have been oversized, and could expose patients to a dangerously high level of the drug's active ingredient.The Food & Drug Administration (FDA) deemed the Digitek recall a Class I recall, meaning that the defective Digitek tablets could cause serious...

Following Digitek, Other Drug Recalls, Feds Seek to Shutter Actavis Facilities

Nov 18, 2008 | Parker Waichman LLP
Actavis Totowa, LLC, the maker of defective Digitek tablets, now faces a lawsuit filed by the U.S. Justice Department that seeks to shut down substandard manufacturing plants in New Jersey.   In April 2008, Actavis Totowa recalled Digitek tablets because some of the medication contained twice the active ingredient normally found in Digitek.  According to the Food & Drug Administration (FDA), the Digitek defect could cause serious and even fatal reactions in users. The FDA...

More Digitek News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo